18-33740369-C-G
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_030632.3(ASXL3):āc.2965C>Gā(p.Arg989Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00182 in 1,609,562 control chromosomes in the GnomAD database, including 11 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ).
Frequency
Consequence
NM_030632.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ASXL3 | NM_030632.3 | c.2965C>G | p.Arg989Gly | missense_variant | 11/12 | ENST00000269197.12 | NP_085135.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ASXL3 | ENST00000269197.12 | c.2965C>G | p.Arg989Gly | missense_variant | 11/12 | 5 | NM_030632.3 | ENSP00000269197 | P4 |
Frequencies
GnomAD3 genomes AF: 0.00122 AC: 186AN: 152076Hom.: 2 Cov.: 33
GnomAD3 exomes AF: 0.00119 AC: 288AN: 241826Hom.: 0 AF XY: 0.00119 AC XY: 156AN XY: 131090
GnomAD4 exome AF: 0.00188 AC: 2746AN: 1457368Hom.: 9 Cov.: 33 AF XY: 0.00189 AC XY: 1368AN XY: 724682
GnomAD4 genome AF: 0.00120 AC: 183AN: 152194Hom.: 2 Cov.: 33 AF XY: 0.00116 AC XY: 86AN XY: 74398
ClinVar
Submissions by phenotype
not provided Benign:3
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Apr 22, 2019 | This variant is associated with the following publications: (PMID: 28785287) - |
Benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Oct 01, 2024 | ASXL3: BP4, BS1, BS2 - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Genetic Services Laboratory, University of Chicago | Nov 22, 2016 | - - |
ASXL3-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Mar 01, 2022 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Severe feeding difficulties-failure to thrive-microcephaly due to ASXL3 deficiency syndrome Benign:1
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Dec 05, 2021 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at